emtricitabine-tenofovir on SilverScript Choice (S5601-044)
generic Truvada
Covered.
Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.
$34.82
Patient pays / month, after deductible
$105.51
Patient pays / month, before the $615.00 deductible
$104.45
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $105.51 for a month. Other covered strengths are listed below.
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated | 4 | $34.82 | 30 per 30 days |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated | 5 | $341.28 | 30 per 30 days |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated | 5 | $341.28 | 30 per 30 days |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated | 4 | $450.49 | 30 per 30 days |
Other HIV drugs on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-044